Home blood tests developer company
Thriva has raised €14M across 4 funding rounds from 10 investors, most recently a Series A round in May 2020. Based in London, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2020-05-25 | Series A | €4.4M | Target Global | View deal → |
| 2019-07-01 | Series A | €6.7M | Guinness Asset Management,Pembroke VCT | View deal → |
| 2017-09-06 | Seed | €1.6M | 500 Startups,Alex Chesterman,SEEDcamp,Simon Franks,Taavet Hinrikus,the London Co-Investment Fund (LCIF) | View deal → |
| 2017-06-13 | Other | €1.7M | 500 Startups,Alex Chesterman,London Co-Investment Fund,SEEDcamp,Simon Franks,Taavet Hinrikus | View deal → |
